Welcome to our dedicated page for Venus Concept SEC filings (Ticker: VERO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Venus Concept Inc. (NASDAQ: VERO) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered tools to help interpret them. Venus Concept is a medical aesthetic technology company that files a range of documents with the U.S. Securities and Exchange Commission, including Current Reports on Form 8-K, annual reports on Form 10-K and quarterly reports on Form 10-Q.
For Venus Concept, Form 8-K filings are particularly important because they document material events such as bridge loan amendments, consent agreements, delayed drawdowns, debt-to-equity exchanges and amendments to preferred stock designations. Recent 8-Ks describe multiple amendments to the company’s Main Street Priority Loan and Bridge Loan with affiliates of Madryn Health Partners, waivers of minimum liquidity covenants, and extensions of loan maturity dates. Other 8-Ks report the exchange of subordinated convertible notes for shares of Series Y Convertible Preferred Stock and changes to the certificate of designations for that preferred stock.
Investors can also use this page to locate earnings-related filings, such as 8-Ks furnished under Item 2.02 that attach press releases for quarterly results, where Venus Concept discusses revenue by region (United States and International), revenue by product category (Venus Prime / subscription systems, products – systems, products – other, and services), gross profit and operating loss. These filings complement the more detailed financial statements and risk disclosures found in the company’s 10-Q and 10-K reports.
Stock Titan enhances these documents with AI-powered summaries and highlights, helping readers quickly identify key points in long filings, such as new financing terms, covenant waivers, strategic transaction agreements (including the definitive agreement to sell the Venus Hair business), and changes to capital structure. Users can also review insider and related-party information where reported, and track how Venus Concept’s financing arrangements and strategic initiatives evolve over time through successive filings.
Venus Concept Inc. is filing multiple post-effective amendments to its Form S-3 shelf registrations to deregister all unsold securities that had previously been registered. These changes are tied to the company’s decision to leave the U.S. public markets.
The board approved a plan on January 20, 2026 to voluntarily delist the company’s common stock from the Nasdaq Capital Market, suspend its duty to file periodic reports and other information with the SEC, and terminate the registration of its common stock under U.S. federal securities laws.
Venus Concept Inc. has filed post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that were previously registered. This step follows the Board’s January 20, 2026 approval of a plan to voluntarily delist the company’s common stock from the Nasdaq Capital Market, suspend its SEC reporting obligations, and terminate the registration of its common stock under U.S. federal securities laws.
Venus Concept Inc. has filed post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that were previously registered for potential sale. This step effectively removes the remaining capacity to issue or resell securities under those shelf registrations.
The company notes that its board of directors approved a plan on January 20, 2026 to voluntarily delist its common stock from the Nasdaq Capital Market, suspend its duty to file periodic reports with the SEC, and terminate the registration of its common stock under U.S. federal securities laws. The deregistration of unsold S-3 securities aligns with this broader move away from U.S. public market reporting status.
Venus Concept Inc. filed post-effective amendments to several Form S-3 registration statements to deregister all unsold securities that had previously been registered for potential sale. This step follows the board’s January 20, 2026 decision to voluntarily delist the company’s common stock from the Nasdaq Capital Market, suspend its obligation to file periodic reports with the SEC, and terminate the registration of its common stock under U.S. federal securities laws.
Venus Concept Inc. is filing post-effective amendments to multiple Form S-3 registration statements to deregister all unsold securities that had previously been registered. This step follows a Board decision on January 20, 2026 to voluntarily delist the company’s common stock from the Nasdaq Capital Market and terminate its registration under U.S. federal securities laws.
The company also plans to suspend its duty to file periodic reports and other information with the SEC, meaning investors may receive less frequent and less standardized public financial disclosure going forward.